Navigation Links
Increased Sensitivity in Microarray Analysis

Transcriptor Reverse Transcriptase in the Eberwine Target Preparation Workflow

Reproducibility and sensitivity are key parameters for the quality of a gene expression profiling experiment. The improved reliability of commercially available microarray platforms has shifted the focus to target preparation as a critical step in microarray analysis. Most of the suppliers of array system platforms recommend the linear amplification of cRNA utilizing T7 RNA polymerase for the synthesis of a labeled target, as first described by van Gelder and Eberwine [1]. With this method, maximum sensitivity can be achieved, especially when starting from a few micrograms of total RNA.

Target Preparation
The first step of this target preparation protocol is the efficient synthesis of cDNA with an oligo(dT)-T7 primer containing a specific T7 promoter sequence at the 5 end. This allows subsequent in vitro transcription of the ds cDNA with T7 RNA polymerase, generating singlestranded labeled cRNA as the target for array hybridization. Transcriptor Reverse Transcriptase (included in the Microarray cDNA Synthesis Kit) is optimized for the efficient transcription of long mRNA, resulting in high yields and sensitivity of cRNA targets.

For a direct comparison of sensitivity and reproducibility of target preparation, we have generated target triplicates from two different human leukemia research samples using (a) the Roche Applied Science (RAS) Microarray Kits and (b) reagents and protocols from Supplier A (Figure 1). The biotin-labeled cRNAs were hybridized to HG-U133A GeneChip arrays from Affymetrix according to the manufacturers protocols. Data analysis was performed using the Affymetrix platform- specific software (present calls, signal intensity values) and MS Excel for calculation of the correlation factors (r2).

Data Analysis
We first analyzed the present call percentage. The number of present calls equals the number of genes (probe sets) that are detectable on a chip. This number corresponds to the genes being expressed in the particular sample.



A significant increase in the number of present calls was observed for both samples when labeled targets were prepared with the RAS Microarray Kits as shown in Table 1.



Figure 2 shows the distribution of the present calls in more detail. The genes analyzed are those that were detected with all three target replicates, prepared by the indicated workflow. For sample 1, 10,339 genes were found to be present when targets were prepared with the RAS Microarray Kits. Of these, 9,331 were also detected with all three targets prepared by Supplier As workflow.



For sample 2, when targets were prepared with the RAS Microarray Kits, 9,652 genes were detected. 7,887 of these genes were also detected with all three targets when Supplier As workflow had been used.

Using the RAS Microarray Kit workflow for target preparation, we identified 185 genes for sample 1 and 283 genes for sample 2 that could not be detected with any replicate when targets where prepared by Supplier As workflow. Vice versa, only 63 genes for sample 1 and 21 genes for sample 2 were not detected with targets prepared with the RAS Microarray Kits

A higher call rate and a larger number of uniquely detected genes are consistently observed for targets generated with the RAS Microarray Kits, indicating increased sensitivity.

Furthermore, correlation factors were calculated for a pair-wise comparison of the three chips hybridized with target replicates; only genes detected with all three target replicates were included in the calculation (Table 2). For chips hybridized with targets that were generated using the RAS Micorarray Kit workflow, correlation is very good (> 0.99) for all pair-wise comparisons. When targets were prepared with Supplier As workflow the correlation is somewhat lower. The good correlation observed for chips hybridized with targets synthesized with the RAS Microarray Kits demonstrates the high reproducibility of the RAS target preparation procedure.

In summary, our data show that the RAS Microarray Kit workflow for target preparation consistently leads to very sensitive and highly reproducible microarray results.




'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Increased Transfer Efficiency Using a Discontinuous Buffer System With the Trans-Blot SD Cell
2. Increased Analyte Sensitivity through the Utility of Enhanced Mass-Resolution on the FinniganTSQ Quantum Discovery
3. Improved Sensitivity for Staining RNA with SYBR Gold Stain
4. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
5. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
6. Femtogram Sensitivity of the Antipsychotic Drugs Raclopride and Ritanserin Using a Varian 1200L LC/MS/MS
7. Maintaining High Sensitivity when Working with Small-Volume Samples
8. High Sensitivity, Wide Dynamic Range, Horseradish Peroxidase (HRP) ELISA Using the LMax Microplate Luminometer (MaxLine Application Note #41)
9. Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
10. Trace Analysis Optimizing Sensitivity Finnigan Surveyor PDA Detector
11. A Screen of shRNAs Targeting Tumor Suppressor Genes to Identify Factors Involved in Paclitaxel Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Increased Sensitivity Microarray Analysis

(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Oct. 5 C3i, the leader in technology services ... a leading global biopharmaceutical company, will deliver a joint ... newest version of Oracle Clinical/Remote Data Capture (OCRDC) software. ... Oracle Health Sciences User Group conference (OHSUG) in San ...
... Group, Inc. (OTC Bulletin Board: MDXG ), ... biomaterial-based products, announced today that its results for the ... before the opening of the market on Tuesday, October ... of its third quarter conference call on October 26, ...
... pressing concerns of the day, fear of plague probably isn,t ... whose responsibility it is to combat bioterrorism, plague is among ... like medical researcher Steve Smiley, whose lab at the Trudeau ... the public against weaponized forms of plague. The Institute, which ...
Cached Biology Technology:C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference 2MiMedx Group, Inc. Announces Release Date For Third Quarter Results 2Plague researchers race to beat bioterrorists 2Plague researchers race to beat bioterrorists 3
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
(Date:12/10/2014)... 2014 Research and Markets ( ... "Biometrics Market in Japan 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of biometrics ... banking and upgradation of the driver,s license is ... market. Besides the aforementioned projects, biometrics is being ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... new mobile app has been launched this week to help ... the inner ear. The tool will allow sufferers of ... how they compare with people across the country. Mnire,s ... cause tinnitus, hearing loss, vertigo and a feeling of pressure ...
... January 29, 2014 The Genetics Society of ... Recipients. The five individuals honored are recognized by their ... community. "The 2014 GSA award winners are ... of genetics in research, in education, and in fostering ...
... 29, 2014 Myriad Genetics, Inc. (NASDAQ: MYGN) today ... with its Prolaris test, at the 2014 ASCO Genitourinary ... demonstrated the significant clinical value of Prolaris to physicians ... is a prognostic test that accurately predicts prostate cancer-specific ...
Cached Biology News:New app to monitor Ménière's Disease launched 2Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 2Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 3Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 4Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 5Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 6Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 7Genetics Society of America selects 5 geneticists to receive society's 2014 Awards 8Myriad's Prolaris significantly modifies treatment decisions for prostate cancer patients 2
... Microarrays designed for DNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... our comprehensive DNA/RNA Aptamer Microarray Service. ... Aptamer Microarray contains greater than 1500 known ...
... Microarrays designed for DNA aptamer screening and ... and powerful Paraflo microfluidic on-chip synthesis platform. ... synthesized on-chip and LC Sciences can provide ... are available as part of our comprehensive ...
... glutathione-S-transferase (GST) is commonly used as a ... coli (1). The GSTTag sequence has been ... some cases the solubility of its fusion ... folded form, GSTTag fusion proteins can be ...
... for the use of small interfering RNA ... the RNA interference (RNAi) pathway have generated ... biology fields. siRNA for experimental use can ... enzymatically, and then transfected into the target ...
Biology Products: